Skip to content
Clinical Trials – home
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Sponsor

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Spain Carretera De Cartagena S/n, El Palmar, 30120 Murcia, Spain

About the sponsor

Heart failure, acute decompensated heart failure, and dilated cardiomyopathy are central areas of interest, alongside studies in cardiac resynchronization therapy and recovery of left ventricular function.

  • Acute decompensated heart failure
  • Dilated cardiomyopathy
  • Cardiac resynchronization therapy
  • Left ventricular function

The portfolio also includes work on biomarker-based assessment of clinical stability and imaging outcomes linked to worsening or recovery in cardiac disease.

About Specializations

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia runs clinical trials in conditions such as Diverticulitis, Dilated cardiomyopathy, External cephalic version, Pre-eclampsia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Risedronate Sodium
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Fentanyl Citrate
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Pre-eclampsia

Recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Ovarian cancer

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Imipramine Hydrochloride
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

HIV infection

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Cardiac failure acute

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).